EMERALD ADVISERS LLC
Q3 2026 Form 13-F
LEOLA, PENNSYLVANIA
CIK 0001015083
· CRD 107496
· SEC-registered investment adviser
$3.6B Reported Value Total
EMERALD ADVISERS, LLC reports 43 total accounts under management (AUM). There are 43 discretionary accounts valued at $3,295,095,778, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Source: Form ADV filed 2026-03-31
Reported value
$3.6B
Quarter over quarter
-14.6%
Holdings
224
Top-10 concentration
17.6%
Filing Structure
Reports holdings for
- PGIM INVESTMENTS LLC · File #028-19510 · Q1 2024 – Q4 2024 · declared by one filing
- AST Investment Services,inc (not a 13F filer in our records) · File #028-19512 · Q1 2019 – Q3 2020 · declared by one filing
Key People
Form ADV owners & control persons
John Thomas Hailer
MEMBER/MANAGER
James Andrew Meehan
CHIEF COMPLIANCE OFFICER
Kenneth George Mertz
CHIEF EXECUTIVE OFFICER, PRESIDENT AND DIRECTOR
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q3 2026 13F record
Q3 2026 13F filing summary
| Period of report | September 30, 2026 |
|---|---|
| Filed | November 09, 2026 |
| Form | 13F-HR |
| Reported value | $3.6B |
| Positions | 224 |
| Change in reported value | -14.3% |
| New positions | 16 |
| Exited positions | 29 |
| Position turnover | 17.8% |
| Top-10 concentration | 17.6% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 9, 2026
|
224 | $3.6B |
|
Q2 2026 13F
Filed Aug 5, 2026
|
237 | $4.2B |
|
Q1 2026 13F
Filed May 4, 2026
|
248 | $3.2B |
|
Q4 2025 13F
Filed Feb 9, 2026
|
246 | $3.2B |
|
Q3 2025 13F
Filed Oct 30, 2025
|
256 | $3.1B |
|
Q2 2025 13F
Filed Aug 4, 2025
|
248 | $2.7B |
|
Q1 2025 13F
Filed May 1, 2025
|
243 | $2.2B |
|
Q4 2024 13F
Filed Feb 11, 2025
|
254 | $2.6B |
|
Q3 2024 13F
Filed Oct 29, 2024
|
248 | $2.6B |
|
Q2 2024 13F
Filed Aug 6, 2024
|
247 | $2.4B |
|
Q1 2024 13F
Filed May 8, 2024
|
243 | $2.5B |
|
Q4 2023 13F
Filed Feb 5, 2024
|
242 | $2.3B |
|
Q3 2023 13F
Filed Oct 26, 2023
|
232 | $2.1B |
|
Q2 2023 13F
Filed Jul 25, 2023
|
211 | $2.3B |
|
Q1 2023 13F
Filed May 4, 2023
|
210 | $2.1B |
|
Q4 2022 13F
Filed Feb 3, 2023
|
245 | $2.1B |
|
Q3 2022 13F
Filed Oct 25, 2022
|
243 | $1.9B |
|
Q2 2022 13F
Filed Jul 29, 2022
|
245 | $1.9B |
|
Q1 2022 13F
Filed Apr 29, 2022
|
257 | $2.6B |
|
Q4 2021 13F
Filed Feb 2, 2022
|
276 | $2.7B |
34 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q3 2026
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | TVTX TRAVERE THERAPEUTICS INC | $92.1M | 2.53% |
| 2 | CORT CORCEPT THERAPEUTICS INC | $87.4M | 2.4% |
| 3 | IDCC INTERDIGITAL INC PA COM | $73.8M | 2.03% |
| 4 | SXT SENSIENT TECHNOLOGIES CORP | $61.1M | 1.68% |
| 5 | COHU COHU INC | $57.0M | 1.57% |
| 6 | SMTC SEMTECH CORP | $54.7M | 1.5% |
| 7 | PLXS PLEXUS CORP | $54.3M | 1.49% |
| 8 | MRCY MERCURY SYSTEMS INC | $53.5M | 1.47% |
| 9 | VSEC VSE CORPORATION | $53.1M | 1.46% |
| 10 | CECO CECO ENVIRONMENTAL CORP | $52.1M | 1.43% |
| 11 | LIVN LIVANOVA PLC | $51.9M | 1.43% |
| 12 | COGT COGENT BIOSCIENCES INC | $51.7M | 1.42% |
| 13 | KLIC KULICKE AND SOFFA INDUSTRIES | $51.4M | 1.41% |
| 14 | SYRE SPYRE THERAPEUTICS | $50.8M | 1.4% |
| 15 | AIR AAR CORPORATION | $50.8M | 1.39% |
| 16 | VRNS VARONIS SYSTEMS INC | $50.1M | 1.37% |
| 17 | ESE ESCO TECHNOLOGIES INC | $50.0M | 1.37% |
| 18 | UMBF UMB FINANCIAL CORP | $49.2M | 1.35% |
| 19 | GH GUARDANT HEALTH INC | $48.8M | 1.34% |
| 20 | AX AXOS FINANCIAL INC | $46.7M | 1.28% |
Values as reported on the Q3 2026 Form 13F. Every position is in the holdings table below.